105 related articles for article (PubMed ID: 20642103)
1. [Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators].
Kohut M; Kacperek-Hartleb T; Sojka D; Hartleb M
Pol Merkur Lekarski; 2010 Jun; 28(168):454-8. PubMed ID: 20642103
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
3. Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease.
Riché F; Dosquet C; Panis Y; Valleur P; Laisné MJ; Briard C; Wautier JL
J Am Coll Surg; 1995 Jun; 180(6):718-24. PubMed ID: 7773486
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
5. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
Van Assche G; Herrmann KA; Louis E; Everett SM; Colombel JF; Rahier JF; Vanbeckevoort D; Meunier P; Tolan D; Ernst O; Rutgeerts P; Vermeire S; Aerden I; Oortwijn A; Ochsenkühn T
J Crohns Colitis; 2013 Dec; 7(12):950-7. PubMed ID: 23411006
[TBL] [Abstract][Full Text] [Related]
6. [Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease].
Kohut M; Hartleb M; Hartleb T
Pol Merkur Lekarski; 2010 Sep; 29(171):169-72. PubMed ID: 20931826
[TBL] [Abstract][Full Text] [Related]
7. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
Jones J; Loftus EV; Panaccione R; Chen LS; Peterson S; McConnell J; Baudhuin L; Hanson K; Feagan BG; Harmsen SW; Zinsmeister AR; Helou E; Sandborn WJ
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
[TBL] [Abstract][Full Text] [Related]
8. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
9. Clinically active Crohn's disease in the presence of a low C-reactive protein.
Florin TH; Paterson EW; Fowler EV; Radford-Smith GL
Scand J Gastroenterol; 2006 Mar; 41(3):306-11. PubMed ID: 16497618
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
11. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
Sikora JP; Kuzański W; Andrzejewska E
Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
[TBL] [Abstract][Full Text] [Related]
12. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease.
Thalmaier D; Dambacher J; Seiderer J; Konrad A; Schachinger V; Pfennig S; Otte JM; Crispin A; Göke B; Ochsenkühn T; Lohse P; Brand S
Aliment Pharmacol Ther; 2006 Oct; 24(7):1105-15. PubMed ID: 16984505
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of C-reactive protein with activity of Crohn's disease].
Yang CH; Chen XY; Yang F; Ran ZH; Liu WZ; Xiao SD
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1253-5. PubMed ID: 16796884
[TBL] [Abstract][Full Text] [Related]
14. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
[TBL] [Abstract][Full Text] [Related]
15. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
[TBL] [Abstract][Full Text] [Related]
16. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity.
D'Auria L; Mussi A; Bonifati C; Mastroianni A; Giacalone B; Ameglio F
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):11-5. PubMed ID: 10188143
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.
Chamouard P; Richert Z; Meyer N; Rahmi G; Baumann R
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):882-7. PubMed ID: 16630759
[TBL] [Abstract][Full Text] [Related]
19. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial.
Krebs S; Omer TN; Omer B
Phytomedicine; 2010 Apr; 17(5):305-9. PubMed ID: 19962291
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.
Reinisch W; Gasché C; Tillinger W; Wyatt J; Lichtenberger C; Willheim M; Dejaco C; Waldhör T; Bakos S; Vogelsang H; Gangl A; Lochs H
Am J Gastroenterol; 1999 Aug; 94(8):2156-64. PubMed ID: 10445543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
